The Potential Role of Changes in the Glucose and Lipid Metabolic Pathways in Gastrointestinal Cancer Progression: Strategy in Cancer Therapy

被引:2
作者
Ferns, Gordon A. [1 ]
Shahini Shams Abadi, Milad [2 ,3 ]
Raeisi, Ahmad [4 ]
Arjmand, Mohammad-Hassan [3 ,5 ]
机构
[1] Brighton & Sussex Med Sch, Div Med Educ, Brighton, E Sussex, England
[2] Shahrekord Univ Med Sci, Basic Hlth Sci Inst, Cellular & Mol Res Ctr, Dept Microbiol & Immunol, Shahrekord, Iran
[3] Shahrekord Univ Med Sci, Canc Res Ctr, Shahrekord, Iran
[4] Shahrekord Univ Med Sci, Hajar Hosp, Clin Res Dev Unit, Shahrekord, Iran
[5] Shahrekord Univ Med Sci, Basic Hlth Sci Inst, Med Plants Res Ctr, Shahrekord, Iran
关键词
Gastrointestinal tumors; Glucose metabolism; Lipid metabolism; Cancer metabolism; FATTY-ACID SYNTHASE; ATP CITRATE LYASE; POSITRON-EMISSION-TOMOGRAPHY; SQUAMOUS-CELL CARCINOMA; PYRUVATE-KINASE M2; HEPATOCELLULAR-CARCINOMA; COLORECTAL-CANCER; COLON-CANCER; DRUG-RESISTANCE; POOR-PROGNOSIS;
D O I
10.1159/000517771
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Changes in cell metabolism are a well-known feature of some cancers, and this may be involved in the etiology of tumor formation and progression, as well as tumor heterogeneity. These changes may affect fatty acid metabolism and glycolysis and are required to provide the increase in energy necessary for the high rate of proliferation of cancer cells. Gastrointestinal cancers remain a difficult-to-treat cancer, particularly as they are usually diagnosed at a late stage of disease and are associated with poor outcomes. Summary: Recently, the changes in the metabolic pathways, including the expression of the rate-limiting enzymes involved, have been considered to be a potential target for therapy for gastrointestinal tumors. Key Message: A combination of routine chemotherapy drugs with metabolic inhibitors may improve the effectiveness of treatment.
引用
收藏
页码:169 / 176
页数:8
相关论文
共 85 条
  • [1] ATP citrate lyase is an important component of cell growth and transformation
    Bauer, DE
    Hatzivassiliou, G
    Zhao, FP
    Andreadis, C
    Thompson, CB
    [J]. ONCOGENE, 2005, 24 (41) : 6314 - 6322
  • [2] Lipid metabolic reprogramming in cancer cells
    Beloribi-Djefaflia, S.
    Vasseur, S.
    Guillaumond, F.
    [J]. ONCOGENESIS, 2016, 5 : e189 - e189
  • [3] Metabolic pathways promoting cancer cell survival and growth
    Boroughs, Lindsey K.
    DeBerardinis, Ralph J.
    [J]. NATURE CELL BIOLOGY, 2015, 17 (04) : 351 - 359
  • [4] GLUT-1 expression and response to chemoradiotherapy in rectal cancer
    Brophy, Sarah
    Sheehan, Katherine M.
    McNamara, Deborah A.
    Deasy, Joseph
    Bouchier-Hayes, David J.
    Kay, Elaine W.
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2009, 125 (12) : 2778 - 2782
  • [5] Deregulation of signalling pathways in prognostic subtypes of hepatocellular carcinoma: Novel insights from interspecies comparison
    Calvisi, Diego F.
    Frau, Maddalena
    Tomasi, Maria L.
    Feo, Francesco
    Pascale, Rosa M.
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2012, 1826 (01): : 215 - 237
  • [6] Glucose uptake inhibitor sensitizes cancer cells to daunorubicin and overcomes drug resistance in hypoxia
    Cao, Xianhua
    Fang, Lanyan
    Gibbs, Seth
    Huang, Ying
    Dai, Zunyan
    Wen, Ping
    Zheng, Xincheng
    Sadee, Wolfgang
    Sun, Duxin
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 59 (04) : 495 - 505
  • [7] Cholesterol biosynthesis supports the growth of hepatocarcinoma lesions depleted of fatty acid synthase in mice and humans
    Che, Li
    Chi, Wenna
    Qiao, Yu
    Zhang, Jie
    Song, Xinhua
    Liu, Ye
    Li, Lei
    Jia, Jiaoyuan
    Pilo, Maria G.
    Wang, Jingxiao
    Cigliano, Antonio
    Ma, Zhilong
    Kuang, Wenhua
    Tang, Zefang
    Zhang, Zemin
    Shui, Guanghou
    Ribback, Silvia
    Dombrowski, Frank
    Evert, Matthias
    Pascale, Rosa Maria
    Cossu, Carla
    Pes, Giovanni Mario
    Osborne, Timothy F.
    Calvisi, Diego F.
    Chen, Xin
    Chen, Ligong
    [J]. GUT, 2020, 69 (01) : 177 - 186
  • [8] The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
    Christofk, Heather R.
    Vander Heiden, Matthew G.
    Harris, Marian H.
    Ramanathan, Arvind
    Gerszten, Robert E.
    Wei, Ru
    Fleming, Mark D.
    Schreiber, Stuart L.
    Cantley, Lewis C.
    [J]. NATURE, 2008, 452 (7184) : 230 - U74
  • [9] Pyruvate kinase M2 is a phosphotyrosine-binding protein
    Christofk, Heather R.
    Vander Heiden, Matthew G.
    Wu, Ning
    Asara, John M.
    Cantley, Lewis C.
    [J]. NATURE, 2008, 452 (7184) : 181 - U27
  • [10] Links between metabolism and cancer
    Dang, Chi V.
    [J]. GENES & DEVELOPMENT, 2012, 26 (09) : 877 - 890